Cara Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	37.9	51.78	63.74	13.45	31.68
Short-Term Investments	-	48.98	81.66	153.58	149.24
Cash & Short-Term Investments	37.9	100.76	145.4	167.04	180.93
Cash Growth	-62.38%	-30.70%	-12.95%	-7.68%	16.72%
Accounts Receivable	0.41	2.77	3.26	-	-
Other Receivables	4.09	1.25	1.19	1.15	2.06
Receivables	4.5	4.02	4.45	1.15	2.06
Inventory	0.9	2.82	2.38	2.58	-
Prepaid Expenses	0.53	8.15	16.27	2.52	12.08
Restricted Cash	-	0.41	0.41	-	-
Total Current Assets	43.83	116.16	168.91	173.29	195.07
Property, Plant & Equipment	-	8.19	1.98	3.6	5.12
Long-Term Investments	-	-	11.35	69.75	70.57
Other Long-Term Assets	-	1.5	-	0.41	0.41
Total Assets	43.83	125.84	182.24	247.06	271.16
Accounts Payable	1.43	11.58	9.6	5.63	4.89
Accrued Expenses	2.54	14.01	11.94	10.24	11.99
Current Portion of Leases	-	-	1.92	1.76	1.6
Total Current Liabilities	3.97	25.59	23.46	17.62	18.48
Long-Term Debt	44.45	37.08	-	-	-
Long-Term Leases	-	6.09	-	1.92	3.67
Total Liabilities	48.42	68.76	23.46	19.53	22.16
Common Stock	0.01	0.01	0.05	0.05	0.05
Additional Paid-In Capital	751.01	742.09	726.63	708.59	641.2
Retained Earnings	-755.61	-684.75	-566.23	-480.76	-392.32
Comprehensive Income & Other	-	-0.26	-1.67	-0.36	0.07
Shareholders' Equity	-4.59	57.09	158.78	227.52	249
Total Liabilities & Equity	43.83	125.84	182.24	247.06	271.16
Total Debt	44.45	43.17	1.92	3.67	5.28
Net Cash (Debt)	-6.55	57.59	154.83	233.12	246.22
Net Cash Growth	-	-62.80%	-33.58%	-5.32%	15.14%
Net Cash Per Share	-4.30	38.29	103.89	165.46	184.99
Filing Date Shares Outstanding	1.52	1.52	1.5	1.49	1.39
Total Common Shares Outstanding	1.52	1.51	1.49	1.49	1.39
Working Capital	39.86	90.57	145.45	155.67	176.58
Book Value Per Share	-3.01	37.72	106.25	153.15	179.74
Tangible Book Value	-4.59	57.09	158.78	227.52	249
Tangible Book Value Per Share	-3.01	37.72	106.25	153.15	179.74
Machinery	-	0.84	0.57	0.57	1.17
Leasehold Improvements	-	4.15	1.27	1.22	1.21

Updated Mar 11, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q